Report cover image

Contract Pharmaceutical Dose Manufacturing Industry: Composition, Size, Market Share and Outlook - 2024 Edition

Publisher GlobalData
Published Nov 15, 2024
Length 65 Pages
SKU # GBDT19429857

Description

Contract Pharmaceutical Dose Manufacturing Industry: Composition, Size, Market Share and Outlook - 2024 Edition



Summary

This expert trend report is a comprehensive look at the pharmaceutical finished dose contract manufacturing landscape in 2024, including analysis of dose CMO M&A activity, market size and share. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the supply chain that will provide insights for supplier selection and management.

Scope

This 65-page report gives an important expert quantitative analysis on the pharmaceutical commercial contract dose manufacturing industry. Findings are based on the industry’s most comprehensive database of the dose CMO industry (GlobalData's Contract Service Providers Database). This analysis is driven by a proprietary model of the dose manufacturing industry, which is continuously updated and refined. The 8 tables and 20 figures throughout the report illustrate major points and trends. This report is required reading for -
  • CMO executives and strategic decision-makers: to improve understanding of the dose CMO industry and provide a critical input for strategic planning efforts.
  • Sourcing and procurement executives in bio/pharmaceutical companies: to improve understanding of crucial components of the supply base that will provide insights for supplier selection and management.
  • Private equity investors: they can gain a deeper understanding of the dose CMO market and important insights for identifying potential investment targets.
Reasons to Buy

This report will enable the user to answer the following questions -
  • What is the geographic reach of commercial dose CMOs?
  • What revenues did the commercial contract dose manufacturing industry generate in the last year?
  • What are the components of revenue change for contract dose manufacturers?
  • What is the breakdown of 2023 revenues by different dosage forms?
  • What are the characteristics of the largest dose CMOs?
  • How did the revenue growth of Contract Dose manufacturers in 2023 compare to Contract API manufacturers?
  • What is the outlook for the dose CMO industry?
  • What is the outlook for GLP-1 receptor agonist products?

Table of Contents

65 Pages
About GlobalData
Table of Contents
Executive Summary
Players
Trends
Industry Analysis
Definition of the dose CMO universe
Industry demographics
Global versus regional reach
Spotlight on injectables
Major developments affecting industry structure
Dose facility acquisitions
Dose company acquisitions
PE acquisitions
Industry Size and Growth
Growth threats and drivers
Growth by dose form
CMO Market Shares
Characteristics of the largest CMOs
GLP-1 Receptor Agonist Sales Forecast
Analyzing Recent Dose CMO Performance
GLP-1 Receptor Agonist Effect
Service-specific growth
Cell and gene therapy
Sponsor-CMO relationships
What it means
Value Chain
Companies
Appendix
Methodology
Methodology for market size and growth estimates
Deal years
CMO classifications
Bibliography
Primary research - key opinion leaders
Further reading
About the Authors
Contact Us
List of Tables
Table 1: Dose CMO trends, 2023
Table 2: CMO acquisitions of dose manufacturing facilities, 2023
Table 3: Summary of CMO facility acquisition of dose facilities activity, 2013-22
Table 4: Dedicated CMO acquisitions of companies with commercial dose capabilities, 2023
Table 5: PE investments in the dose CMO industry, 2013-23
Table 6: Dose revenue composition and capabilities of leading CMOs, 2023
Table 7: Geographical reach of dose CMO universe, 2023
Table 8: Further reading
List of Figures
Figure 1: Leading dose CMOs, 2023
Figure 2: Top contract dose trends in the CMO industry, 2023
Figure 3: Geographic reach of the dose CMO universe, 2023
Figure 4: Geographic distribution of commercial dose facilities, 2023
Figure 5: Geographic distribution of commercial dose injectable facilities, 2023
Figure 6: Dose CMO revenue, 2013-23
Figure 7: Components of growth for dose CMOs, 2022-23
Figure 8: Dose CMO dosage form revenue segments in 2023 ($B)
Figure 9: Dose CMO dosage form revenue segments percentage change from 2022-23 (%)
Figure 10: CMO count by dose revenue tiers, 2023
Figure 11: Dose CMO industry market share by company revenue tier, 2023
Figure 12: Dose CMO industry market share by company revenue tier, percentage change from 2022-23 (%)
Figure 13: Revenue growth for public CMOs
Figure 14: Marketed GLP-1 receptor agonist sales forecasts, 2023-27
Figure 15: Pipeline GLP-1 receptor agonist sales forecasts, 2023-27
Figure 16: CMO services sector performance, 2023
Figure 17: GLP-1 receptor agonists’ contract manufacturing agreements
Figure 18: Dose outsourcing of FDA NME approvals by sponsor market cap
Figure 19: NME dose outsourcing contracts, by sponsor market cap, 2014-23
Figure 20: The contract manufacturing value chain

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us